The 39-year-old vascular surgeon allegedly killed his ex-wife and her husband on Dec. 30. If convicted, he faces the possibility of life in prison without parole.
The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy.
Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.
Gene-editing drugs have shown potential to treat a wide variety of diseases, and this will be one of the first in cardiovascular medicine to begin human trials.
Arizona Attorney General Kris Mayes had accused the Scottsdale-based radiology group of issuing delayed refunds after allegedly using questionable upfront billing practices.
Julie Szeker, the publicly traded company’s chief legal officer and corporate secretary, submitted her resignation on Jan. 12, according to an SEC filing.
The Salt Lake City-based nonprofit is buying Steinberg Diagnostic Medical Imaging for an undisclosed sum, with the integration to be introduced in phases over the coming year.
New data published in JACC represents another big win for Bayer's finerenone. The drug has previously been linked to cardiovascular benefits for patients with CKD and heart failure, but its potential across the full CKM spectrum remained a bit of a mystery.
Radiology recently rose to the second highest paid specialty in medicine, but new data reveals that readers in some cities enjoy significantly higher compensation.
A leaked report from Ernst & Young says President Donald Trump’s proposed 25% tariff on drugs would stifle domestic manufacturing and force the industry to take on an additional $51 billion in annual costs.
